Patent · US Active

Methods of use for trisubstituted benzotriazole derivatives

US11717512B2 · kind B2 · utility

3Cited by
5References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 19, 2019
Grant dateAug 8, 2023
Priority date
Expiry dateMar 21, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods for treating cancer in a subject with a trisubstituted benzotriazole derivative with the formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables R1, R2 and R3 are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.